# Allarity Therapeutics, Inc.: Form 8-K, filed Jun 11, 2025

- Company: [Allarity Therapeutics, Inc.](/companies/allr.md) (CIK 1860657)
- Form: 8-K
- Filed: 2025-06-11
- Accepted by EDGAR: Jun 11, 2025, 16:10 ET
- Period: 2025-06-05
- Accession: 0001437749-25-020081
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1860657/000143774925020081/allr20250611_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1860657/000143774925020081/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1860657/000143774925020081/allr20250611_8k.htm

Filed Jun 11, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-020081. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.